Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

ResMed Inc. News

Chipotle, TakeTwo Among Stocks Hurt by Rising Rates: Bank of America

Bank of America's list is based on the stocks’ relative-performance sensitivity to changes in the 10-year Treasury yield.

ResMed Rises as Royal Philips Recalls Sleep Apnea Devices

Needham analyst Mike Matson, who has a buy rating and $229 price target on ResMed, says the company will be helped by a Royal Philips recall.

Tug-of-War: Cramer's 'Mad Money' Recap (Friday 11/20/20)

The market needs clarity on the vaccine and the election.

Coronavirus Cases Cross 1 Million, Wall Street Awaits Jobs Report - 5 Things You Must Know Friday

Stock futures fall as Wall Street braces for the U.S. jobs report for March and coronavirus infections across the globe surpass 1 million; Tesla delivers its 'best ever' first-quarter performance; American Airlines drastically reduces both domestic and international flights.

Economy’s a Leaky Ship: Cramer's 'Mad Money' Recap (Monday 4/1/20)

Investors can’t fight this kind of selling, but they shouldn’t give up. Jim Cramer’s got a case for sitting tight. It will end.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.